What is NDC 69238-1535?

69238-1535 is the product NDC for Clobazam, Clobazam 2.5 mg/mL suspension, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clobazam?

29 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clobazam NDC 69238-1535 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1535Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1535Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1535-2	6923815350269238153502	1 BOTTLE, GLASS in 1 CARTON (69238-1535-2) / 120 mL in 1 BOTTLE, GLASSMarketed from Oct 22, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clobazam
Generic name (nonproprietary): clobazam
Active ingredients: Clobazam — 2.5 mg/mL
Dosage form: Suspension
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 69238
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210039
Marketing start: Oct 22, 2018
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Benzodiazepines (Chemical structure)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)
Identifiers: Product ID 69238-1535_cf085b2b-564e-4109-90e7-1d27fcbca810SPL ID cf085b2b-564e-4109-90e7-1d27fcbca810SPL set ID a526ad73-d3c1-40b7-8e71-426b01cdea27RxCUI 1366192UNII 2MRO291B4U
Pharmacologic class: Benzodiazepine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238153502 followed by a unit qualifier and the quantity

Package 69238-1535-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 18, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Clobazam oral suspension is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. Clobazam oral suspension is a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 69238-1535

What is NDC 69238-1535?: 69238-1535 is the product NDC for Clobazam, Clobazam 2.5 mg/mL suspension, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clobazam.
What is the active ingredient?: Clobazam.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 69238. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clobazam?: 29 other product NDCs are listed under this name. See all Clobazam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clobazam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Precision Dose, Inc.	68094-074	68094-0074-58
Clobazam	Clobazam 5 mg/1	TabletOral	Ascend Laboratories, LLC	67877-664	67877-0664-0167877-0664-0567877-0664-33
Clobazam	Clobazam 10 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-047	72205-0047-91
Clobazam	Clobazam 20 mg/1	TabletOral	Novadoz Pharmaceuticals LLC	72205-048	72205-0048-91
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Aurobindo Pharma Limited	59651-401	59651-0401-12
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Bryant Ranch Prepack	72162-2608	72162-2608-02
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Sun Pharmaceutical Industries, Inc.	51672-4227	51672-4227-08
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Ascend Laboratories, LLC	67877-658	67877-0658-61
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	NorthStar RxLLC	16714-087	16714-0087-01
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Chartwell RX, LLC	62135-527	62135-0527-41

All 30 Clobazam NDCs

Other NDCs under ANDA 210039

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210039
Product	Strength	Form · route	Labeler	Product NDC
Clobazam	Clobazam 2.5 mg/mL	SuspensionOral	Precision Dose, Inc.	68094-074